首頁 > 市場調查報告書 > 材料

包裝/容器醫藥品包裝

市場調查報告書

商品編碼

1629917

全球永續藥品包裝市場 - 2024-2032

Global Sustainable Pharmaceutical Packaging Market - 2024-2032

出版日期: 2024年12月30日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024年，全球永續藥品包裝市場規模達919.4億美元，預計2032年將達到2,729.8億美元，2024-2032年預測期間複合年成長率為12.7%。

永續藥品包裝包括減少浪費、降低碳排放並促進回收或生物分解性的材料和設計。隨著製藥業面臨來自消費者、監管機構和環境組織的壓力，要求採取更永續的做法，這種方法變得越來越重要。永續包裝不僅有助於減少產業對環境的影響，也符合全球永續發展目標。

市場動態：

驅動程式和限制

消費者對可回收和環保材料的偏好不斷上升

消費者對可回收和環保材料的偏好日益影響永續藥品包裝市場。隨著環境問題的日益嚴重，消費者越來越意識到包裝廢棄物對地球的有害影響。這種意識促使他們倡導製藥公司採用永續實踐，優先考慮由可回收、可生物分解或可再生資源製成的包裝。因此，消費者行為的這種轉變迫使製造商進行創新，並將環保材料融入其產品設計中，以符合具有環保意識的消費者的價值觀。

製造商正在開發創新的永續解決方案，以減少有害塑膠和其他材料對環境的影響。例如，2024年10月30日，拜耳在其知名品牌Aleve上推出了醫療保健產業首創的聚對苯二甲酸乙二醇酯（PET）吸塑包裝。

對環保包裝不斷成長的需求正在推動製藥業對研發的大量投資。公司正在探索傳統塑膠的替代品，選擇玻璃、紙張和可生物分解聚合物等材料。例如，2023 年 11 月 7 日，ACG 推出了新的永續包裝技術。這些創新旨在增強製藥業的環境責任和營運效率。這些環保包裝解決方案的推出標誌著 ACG 在永續發展和創新承諾方面向前邁出了重要一步。

與環保材料相關的高成本

永續包裝解決方案通常需要先進的技術、專用材料和獨特的生產流程，這可能導致製造成本顯著增加。對於利潤率較低的製藥公司來說，這些額外費用可能會帶來相當大的挑戰。此外，與某些環保材料（例如可生物分解塑膠和再生資源）相關的價格波動會導致金融不穩定，從而阻礙其在市場上更廣泛的採用。

Sustainable pharmaceutical packaging encompasses materials and designs that reduce waste, lower carbon emissions, and promote recycling or biodegradability. This approach is increasingly important as the pharmaceutical industry faces pressure from consumers, regulators, and environmental organizations to adopt more sustainable practices. Sustainable packaging not only helps in reducing the industry's environmental impact but also aligns with global sustainability goals.

Market Dynamics: Drivers & Restraints

Rising consumer preference for recyclable and eco-friendly materials

Consumer preference for recyclable and eco-friendly materials is increasingly influencing the sustainable pharmaceutical packaging market. As environmental concerns rise, consumers are becoming more aware of the detrimental effects of packaging waste on the planet. This awareness is prompting them to advocate for pharmaceutical companies to adopt sustainable practices, prioritizing packaging made from recyclable, biodegradable, or renewable resources. Consequently, this shift in consumer behavior is compelling manufacturers to innovate and integrate eco-friendly materials into their product designs, aligning with the values of environmentally conscious consumers.

Manufacturers are developing innovative sustainable solutions to reduce the impact of harmful plastic and other materials on the environment. For instance, on October 30, 2024, Bayer launched a first-of-its-kind in the healthcare industry, polyethylene terephthalate (PET) blister packaging on its renowned brand, Aleve.

The growing demand for eco-friendly packaging is driving significant investments in research and development within the pharmaceutical industry. Companies are exploring alternatives to traditional plastics, opting for materials such as glass, paper, and biodegradable polymers. For instance, on November 07, 2023, ACG launched its new sustainable packaging technologies. These innovations are designed to enhance environmental responsibility and operational efficiency within the pharmaceutical sector. The introduction of these eco-friendly packaging solutions marks a significant step forward in ACG's commitment to sustainability and innovation.

High costs associated with eco-friendly materials

Sustainable packaging solutions often require advanced technologies, specialized materials, and unique production processes, which can lead to significantly higher manufacturing costs. For pharmaceutical companies that operate on tight profit margins, these additional expenses can present a considerable challenge. Furthermore, the price fluctuations associated with certain eco-friendly materials, such as biodegradable plastics and renewable resources cause financial instability that could hinder their broader adoption in the market.

Segment Analysis

The global sustainable pharmaceutical packaging market is segmented based on packaging type, process, raw material, product type, end-user, and region.

Type:

Recyclable segment is expected to dominate the global sustainable pharmaceutical packaging market share

Recyclable sustainable pharmaceutical packaging is anticipated to dominate the market due to its increasing popularity among consumers, regulatory pressures, and cost-effectiveness. As awareness of environmental concerns continues to grow globally, consumers are seeking packaging solutions that minimize waste and support sustainability.

Recyclable packaging offers a practical, eco-friendly option, allowing pharmaceutical companies to meet consumer demands while reducing their environmental impact. The ability to recycle materials not only helps reduce waste sent to landfills but also supports the circular economy, where resources are reused, making recyclable packaging a preferred solution.

Additionally, the rising initiatives to recycle pharmaceutical wastes and packaging solutions are encouraging the adoption of recyclable packaging solutions in the pharmaceutical industries. For instance, on April 29, 2024, the United Kingdom launched The Circularity in Primary Pharmaceutical Packaging Accelerator (CiPPPA) initiative to develop and implement strategies for the end-of-use recycling of medicinal devices and pharmaceutical packaging.

Moreover, governments worldwide are implementing stricter packaging waste regulations, encouraging companies to shift towards recyclable materials. In response, pharmaceutical manufacturers are adopting recyclable packaging to comply with these policies and avoid potential penalties. Advancements in recycling technology are also enhancing the efficiency and practicality of recycling processes, making recyclable packaging more affordable and viable. This combination of consumer demand, regulatory incentives, and technological improvements is driving recyclable packaging to become a dominant force in the sustainable pharmaceutical packaging market.

Geographical Analysis

North America is expected to hold a significant position in the global sustainable pharmaceutical packaging market share

North America is expected to lead the sustainable pharmaceutical packaging market due to a variety of factors, such as growing consumer demand for eco-friendly products, stricter government regulations, and the presence of major industry players. Consumers in the region are increasingly concerned about environmental issues like climate change and plastic pollution, which has led to a rising demand for more sustainable packaging options.

In response, pharmaceutical companies in North America are focusing on adopting eco-friendly packaging solutions to meet these consumer expectations. This shift is further supported by a collective effort from both consumers and businesses to reduce waste and lessen their environmental impact, making North America a leader in sustainable packaging adoption.

In addition, government policies in North America are playing a significant role in driving the growth of sustainable pharmaceutical packaging. Both the U.S. and Canadian governments have introduced more stringent regulations on environmental practices and packaging waste management, motivating pharmaceutical companies to explore greener alternatives.

North America has several pharmaceutical manufacturers and packaging providers who are investing in new technologies and research to create innovative, sustainable packaging materials. For instance, in October 2024, Berry Global launched a range of clarified polypropylene (PP) bottles for healthcare applications, which offer sustainability and enhanced product protection compared to traditional colored PET pill bottles. ClariPPil bottles are ideal for a wide variety of products including vitamins, nutraceuticals, dietary supplements, beauty supplements, and OTC treatments.

This combination of industry collaboration, favorable economic conditions, and access to advanced technologies positions North America as a key driver in the global market for sustainable pharmaceutical packaging.

Asia Pacific is growing at the fastest pace in the global Sustainable Pharmaceutical Packaging market

The Asia Pacific region is experiencing the fastest growth in the global sustainable pharmaceutical packaging market due to several factors, including rapid industrial development, increasing consumer awareness, and evolving government regulations. As pharmaceutical industries in countries like China and India continue to expand, there is an increasing demand for packaging solutions that meet sustainability objectives. This shift is largely driven by a growing, environmentally conscious middle class, which is encouraging companies to embrace eco-friendly packaging alternatives.

The rising concerns about plastic waste and environmental impact in the region are prompting both consumers and businesses to prioritize sustainable packaging options, fueling the growth of the sustainable pharmaceutical packaging sector. The market players in the region are expanding their production of sustainable pharmaceutical packaging solutions which is also contributing to the region's market growth. For instance, on 6 November 2023, Amcor launched the next generation of its Medical Laminates solutions. Amcor's latest innovation enables the development of all-film packaging that is recyclable in the polyethylene stream. The new solution reduces the carbon footprint of the final package while maintaining the performance requirements of device applications, helping medical companies to progress their sustainability goals without compromising patient safety.

Competitive Landscape

The major global players in the sustainable pharmaceutical packaging market include Amcor plc, Berry Global Inc., Gerresheimer AG, WestRock Company, Drug Plastics & Glass Co., Inc., CCL Healthcare, Comar, Bormioli Pharma S.p.A., Origin Pharma Packaging and Ascend Packaging Systems LLC. among others.

Key Developments

In July 2024, Aluflexpack announced the development of a new product: the 4-Infinity Form. This blister pack, designed specifically for the pharmaceutical industry, is constructed entirely of lacquered aluminum, offering a sustainable and recyclable alternative to traditional multi-material packaging.
April 2022, Amcor announced the addition of new, more sustainable High Shield laminates to its pharmaceutical packaging portfolio. The new low-carbon, recycle-ready packaging options deliver on two fronts, providing the high barrier and performance requirements needed for the industry while supporting pharmaceutical companies' recyclability agendas.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global sustainable pharmaceutical packaging market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Packaging Type
3.2. Snippet by Process
3.3. Snippet by Raw Material
3.4. Snippet by Product Type
3.5. Snippet by End-User
3.6. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising consumer preference for recyclable and eco-friendly materials
- 4.1.2. Restraints
  - 4.1.2.1. High costs associated with eco-friendly materials
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Packaging Type

6.1. Introduction
- 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 6.1.2. Market Attractiveness Index, By Packaging Type
6.2. Primary Packaging*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Secondary Packaging

7. By Process

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
- 7.1.2. Market Attractiveness Index, By Process
7.2. Recyclable*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Reusable
7.4. Biodegradable

8. By Raw Material

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
- 8.1.2. Market Attractiveness Index, By Raw Material
8.2. Paper & Paperboard*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Glass
8.4. Bioplastics
8.5. Metal
8.6. Others

9. By Product Type

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.1.2. Market Attractiveness Index, By Product Type
9.2. Blisters*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Labels & Accessories
9.4. Caps & Closures
9.5. Pre-filled Inhalers
9.6. Vials
9.7. Pre-filled Syringes
9.8. Ampoules
9.9. Cartridges
9.10. Others

10. By Raw Material

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
- 10.1.2. Market Attractiveness Index, By Raw Material
10.2. Paper & Paperboard*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Glass
10.4. Bioplastics
10.5. Metal
10.6. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.8.1. U.S.
  - 11.2.8.2. Canada
  - 11.2.8.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.8.1. Germany
  - 11.3.8.2. U.K.
  - 11.3.8.3. France
  - 11.3.8.4. Spain
  - 11.3.8.5. Italy
  - 11.3.8.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.8.1. Brazil
  - 11.4.8.2. Argentina
  - 11.4.8.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.8.1. China
  - 11.5.8.2. India
  - 11.5.8.3. Japan
  - 11.5.8.4. South Korea
  - 11.5.8.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. Amcor plc*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Berry Global Inc.
13.3. Gerresheimer AG
13.4. WestRock Company
13.5. Drug Plastics & Glass Co., Inc.
13.6. CCL Healthcare
13.7. Comar
13.8. Bormioli Pharma S.p.A.
13.9. Origin Pharma Packaging
13.10. Ascend Packaging Systems LLC.

LIST NOT EXHAUSTIVE